Vertistar MD 8 mg Tablet (10 Tab)

About Vertistar MD 8 mg Tablet:

Vertistar MD 8 mg tablet is prescribed to treat Meniere’s syndrome, a disorder of the inner ear.

Each uncoated dispersible Vertistar MD 8 mg tablet contains Betahistine Dihydrochloride 8 mg.

Betahistine is a histamine analogue and acts as both partial histamine H1-receptor agonist and histamine H3-receptor antagonist in neuronal tissue.
H1-receptor antagonism improves the microcirculation in the labyrinth, thus reduces endolymphatic pressure. This action prevents the rupture of the labyrinth, which can contribute to the hearing loss associated with Meniere’s disease.
H3-receptor antagonism elevates neurotransmitters levels and inhibits the activity of vestibular nuclei. Thus restores proper balance and decreases vertigo symptoms.

Uses of Vertistar MD 8 mg Tablet:

Vertistar MD 8 mg tablet is a histamine analogue medicine, prescribed to treat the symptoms of Meniere’s syndrome such as dizziness (vertigo), ringing in the ears (tinnitus), and loss of hearing.

Usage direction of Vertistar MD 8 mg Tablet:

• Vertistar MD 8 mg tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
• Disperse one Vertistar MD 8 mg tablet in a teaspoonful of water immediately before administration.
• Do not stop or skip the medicine without the physician’s advice.
• Do not exceed the stated recommended daily dosage.

Precaution & Related information of Vertistar MD 8 mg Tablet:

• If hypersensitive or allergic to Vertistar MD 8 mg tablet, inform the physician immediately.
• Inform the physician immediately, if the patient is having any other complications.
• The physician should be aware of the concomitant use of Vertistar MD 8 mg tablet with any other medication.
  
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Vertistar MD 8 mg Tablet:

Store in a dry place at a temperature not exceeding 30°C. Protect from light.